Small Cap News Movers for 11/20/09

Lannett Company, Inc. (NYSE AMEX: LCI) today announced that its Board of Directors has approved a reauthorization of the stock repurchase program. Under the program, the company is authorized to repurchase up to $5 million of Lannett’s outstanding common stock from time to time in open market and privately negotiated transactions. “The repurchase program reflects the board’s optimism and confidence in the future of our company…,” said Arthur Bedrosian, president and chief executive officer. The stock closed at $6.40, up 29.29%, on 208,999 traded shares.

Inovio Biomedical Corp. (NYSE AMEX: INO) announced today that a combination of its synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several different influenza sub-types and strains in ferrets. In addition, ferrets immunized with Inovio’s SynConTM universal flu vaccine combinations were 100% protected against death and sickness in a challenge with the A/H1N1 (2009) swine-origin influenza. The stock closed at $1.53, up 27.51%, on 10,288,133 traded shares.

Advance Nanotech, Inc. (OTCBB: AVNA) reported its financial results for the three months ended September 30, 2009. The Company reported net income of $2,417,351, or $0.04 per share, compared to a loss of $382,555, or $0.01 per share, for the three months ended September 30, 2008, an increase of approximately $2,800,000. Although revenue decreased by 30 percent for the three months ended September 30, 2009, cost of sales decreased by over 67 percent during the same period. The stock closed at $0.081, up 55.77%, on 2,254,599 traded shares.

About QualityStocks:

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. Our name emphasizes the commitment we have to connect subscribers with companies that have huge potential to succeed in the short and long-term future.